| William Nevin, MD | |
|
1951 N Wilmot Rd, Bldg 4, Tucson, AZ 85712-8000 | |
| (520) 318-4691 | |
| (520) 382-2999 |
| Full Name | William Nevin |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 1951 N Wilmot Rd, Tucson, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427055730 | NPI | - | NPPES |
| 203331 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 6858 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Nevin, MD 1951 N Wilmot Rd, Bldg 4, Tucson, AZ 85712-8000 Ph: (520) 318-4691 | William Nevin, MD 1951 N Wilmot Rd, Bldg 4, Tucson, AZ 85712-8000 Ph: (520) 318-4691 |
News Archive
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today further progress on the Company's platform efforts in extrahepatic delivery of novel siRNA conjugates, including central nervous system (CNS) and ocular delivery in rat and non-human primates (NHPs).
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
Vaccines to combat a virus that can lead to fatal lung infections are urgently needed to help prevent child deaths worldwide, research suggests.
According to researchers children exposed to chemicals from food packaging and textile products may have compromised immune systems. They found kids with more perfluorinated compounds, or PFCs, in their blood stream were less likely to respond to routine vaccines.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
› Verified 1 days ago
Dr. Basel Skeif, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5140 E Glenn St, Tucson, AZ 85712 Phone: 520-838-3540 Fax: 520-325-3526 | |
Dr. David Spencer Hamilton Sr., MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3601 S 6th Ave, Tucson, AZ 85723 Phone: 520-792-1450 | |
Diana Silva Cantillo, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1230 S Cherrybell Stra, Tucson, AZ 85713 Phone: 520-628-8287 | |
Basel Shoua, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2070 W Rudasill Rd Ste 130, Tucson, AZ 85704 Phone: 520-797-4468 Fax: 520-797-4502 | |
Hadil Owaynat, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1501 N Campbell Ave Rm 6336, Tucson, AZ 85724 Phone: 520-626-2760 Fax: 520-626-6020 | |
Dr. David M Schwartz, DO Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 6200 N La Cholla Blvd, Tucson, AZ 85741 Phone: 520-469-8011 Fax: 520-469-8021 | |
Kenneth Alex Murachanian, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6060 N Fountain Plaza Dr Ste 270, Tucson, AZ 85704 Phone: 520-229-2578 |